2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).Show others and affiliations
2018 (English)In: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 39, no 3, p. 213-260Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2018. Vol. 39, no 3, p. 213-260
Keywords [en]
Acute coronary syndromes, Aspirin, Bleeding, Clopidogrel, Coronary artery bypass grafting, Coronary artery disease, DAPT score, Drug-eluting stents, Dual antiplatelet therapy, Guidelines, Myocardial infarction, Non-cardiac surgery, Oral anticoagulant, PRECISE-DAPT score, Percutaneous coronary intervention, Prasugrel, Recommendation, Revascularization, Risk stratification, Stable angina, Stable coronary artery disease, Stent thrombosis, Stents, Ticagrelor, Triple therapy
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:uu:diva-342779DOI: 10.1093/eurheartj/ehx419PubMedID: 28886622OAI: oai:DiVA.org:uu-342779DiVA, id: diva2:1185127
Note
Collaborator 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
2018-02-232018-02-232025-02-10